Search

everythinglearnresearchcommunity

for

Search:↓

Higher androgen levels might make COVID-19 worse, especially in men.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Mutations in certain receptors can cause diseases and offer new treatment options.

Post-finasteride patients show changes in gut bacteria, possibly causing various symptoms.

The 2004 hair research meeting presented new findings on hair cell differentiation, genetic factors in hair loss, hair pigmentation, and potential targeted therapies.

The document explains various skin conditions and their treatments.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Hair follicles have a more inactive cell cycle than other skin cells, which may help develop targeted therapies for skin diseases and cancer.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Some drugs can cause reversible hair loss, but certain chemotherapy drugs may lead to permanent hair loss; drugs can also change hair color and texture.

The document concludes that understanding and managing hair loss in cancer patients is important, and more research is needed for better treatments.

Fibroblasts are crucial for tissue repair and inflammation, and understanding them can help treat fibrotic diseases.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

People with certain allergic conditions or higher white blood cell counts have more severe hair loss, and treating hair and nail side effects early in melanoma therapy can improve quality of life.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

Hormonal interactions, especially involving DHT and estrogen, play a key role in BPH development and treatment.

Scientists created cell lines from balding patients and found that cells from the front of the scalp are more affected by hormones that cause hair loss than those from the back.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

Personalized treatments for hair loss are becoming more effective by using genetic information.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Nuclear hormone receptors play a significant role in skin wound healing and could lead to better treatment methods.

Effective treatments for spinal and bulbar muscular atrophy are not yet available; more research is needed.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

Doctors should diagnose hair loss by examining the patient and possibly doing tests, and then treat it based on the type, which may prevent permanent hair loss.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Alternative treatments show promise for hair growth beyond traditional methods.